TEM Tempus AI Inc

TEMPUS AI $TEM Q3’26 EARNINGS HIGHLIGHTS 🔹 Revenue: $411.5M (Est. $409M) 🟢; +23% YoY 🔹 Adj. EPS: $0.07 (Est. -$0.08) 🟢 🔹 Adj. EBITDA: $25.6M Raises FY26 Guide: 🔹 Revenue: $1.60B-$1.61B (Est. $1.59B) 🟢 🔹 Adj. EBITDA: ~$65M Segment Revenue: 🔹 Diagnostics: $303.5M; +20% YoY 🔹 Data & Applications: $108.1M; +33% YoY Announcements: 🔹 FDA: Two 510(k) clearances for ECG-PH and ECG-MR 🔹 Research Platform: 100,000 whole genomes planned Key Updates: 🔹 Data Licensing: >$550M bookings YTD; BMS deals up to $137.5M and $55M 🔹 Personalis acquisition cleared regulatory review Comments: 🔸 “Q3 was another record quarter, as we delivered $411.5 million of revenue, led by accelerating unit growth of 32% in our oncology business and increasing momentum of 33% revenue growth in Data & Applications”

$TEM Q3 '26 Earnings Results & Recap • Reported GAAP EPS of $0.07 up 163.64% YoY • Reported revenue of $411.54M up 23.14% YoY

$TEM The fundamental story backs the chart: pharma data deals are stacking up, margins are improving, and guidance was raised last quarter. The risk is the calendar. You’d be buying a momentum breakout four trading days before a report where the stock has sold off four straight times, even on beats. One way to play it is a partial position now and adding after Monday’s reaction.

$TEM notjing wrong in the earning report..it was superb but still moving slowly upwards..expecting to reach $85 today.. is it too much asking for this earning report?

Some morning trade ideas from my ORB Grok Bot looking for Opening Range Breakout (ORB) strategies. It identifies candidates, then reads the range from 9:30-35 then looks for a breakout over that range before 10am: Today's pick is $TEM (Tempus AI). It beat Q3 estimates and raised its 2026 revenue guidance. It's up 3.43% pre-market on 11.46% of its average volume, and $SPY is up 0.60%. The pick is pending, and I'll watch for a breakout after 9:35 AM ET. $FOXA and $FLNC came close but didn't qualify. FOXA beat earnings but didn't raise guidance, and FLNC's move came from a CEO and CFO change. The pre-market volume figure came from around 9:17 AM ET, so treat it as a little less certain.

$TEM Looking to Swing trade from this area. Will continue to accurate shares till close. ✊🏿

$TEM bullish trend still intact. Sitting at lower trend line. Looking for a bounce here

I can see it now, $TEM is $140 and Jefferies will raise their PT to $140 and upgrade to Outperform. $TEM upgraded to Hold from Buy at Jefferies - raises PT to $70 from $35

$TEM probably sweeps down to 60 then gives you the ramp back holding the psychological level and running stops. Low risk spot at 60-61 vs 56. Below and it’s pretty ugly.

$TEM So unfair. Rich people buy, sell, buy again, rinse and repeat makes billion. At this point, I kind of like the CCP Iran Russia. Fml

$TEM 💥💯💰💰💰💰💰💯💥 EXTREMELY BULLISH SETUP! Double-bottom support near $66.85 is holding strong, price reclaimed both converging EMAs, RSI surged from 16.7 to 53.7, and MACD flipped bullish with an expanding positive histogram. Momentum is shifting decisively toward the bulls, setting the stage for a potential breakout and powerful squeeze!💥🚀💰🏆

$TEM 💥💯🚀💥💯🚀💥💯🚀💥💯🚀 The oversold bounce is forming & RSI is curling out! Time for a nice bounce & accumulation time.

$TEM Looking forward to this week. Hopefully we can make some moves up to 75, then 85 after.

$TEM Daddys average in Tempus shares is now 51 $ after the add at 69$. Holding this probably into the 2030s. Swing trading with puts once this board gets excited again. Not yet.

$TEM wow what a close great big buys end of day ! You are holding a lot of gold TEM ers !

$TEM popped after reporting a Q3 earnings beat with Q3 revenue of $411.5M vs. consensus $409.3M, and EPS of $0.07 vs. consensus (-$0.08). The company raised its full-year 2026 revenue guidance to $1.6B-$1.605B, representing ~25% annual growth. $TEM CEO: "Q3 was another record quarter, as we delivered $411.5M in revenue, led by accelerating unit growth of 32% in our oncology business and increasing momentum of 33% revenue growth in Data & Applications. These results reinforce the durability of our model as our best-in-class diagnostic platform enhances our data and AI offerings, distinguishes our business from competitors, and helps drive quarter-over-quarter performance."

$TEM So far so good with Tempus. It's been a wild market lately with a lot of rug pulls on earnings. Hopefully won't happen here.

$TEM 🔥💥🚀🪎🔥💥🚀🪎 H.C. Wainwright raised its price target on Tempus Al Inc (NASDAQ:TEM) to $85 from $68 while maintaining a Buy rating on the stock.

$TEM sold before close. Not holding through earnings Nov 2nd, looking for a drop in the low $60. Every earning announcement has been a sell the news event. Let the dust settle..

$TEM if Tempus went up 4x it would still be smaller than Natera, so much more room to run